Ethnic differences in cancer incidence: a marker for inherited susceptibility?
- 1 June 1997
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 105 (suppl 4) , 897-900
- https://doi.org/10.1289/ehp.97105s4897
Abstract
Cancer incidence varies markedly by ethnicity and geographic location. Ethnic variation in cancer occurrence has traditionally been ascribed to differences in social, cultural, economic, and physical environments. However, this interpretation of the epidemiologic evidence may need to be revised as a result of new biological evidence and theories of carcinogenesis. Carcinogenesis is now recognized to be a multistep process during which mutations or heritable changes in expression occur in genes involved in cellular growth control and genome stability. Inherited cancer susceptibility may be a stronger determinant of ethnic differences in cancer incidence than is currently appreciated. To examine the potential role of inherited susceptibility, the theoretical contribution of inherited susceptibility to ethnic differences in rates in considered using a simple probability model. Germline mutations in tumor suppressor genes BRCA1 and p53 are used to illustrate the magnitude of the ethnic differences for breast cancer that might arise from differences in inherited susceptibility. Our simple model suggests that ethnic differences in cancer occurrence can result from differences in genetic susceptibility. However, the magnitude of ethnic relative risk is likely to more strongly reflect differences in the distribution of susceptibility genotypes between groups than the magnitude of the disease risk associated with the genotypes. For many scenarios, the ethnic relative risk arising from differences in susceptibility may be bounded by the ratio of the proportion of susceptible individuals in each group.Keywords
This publication has 14 references indexed in Scilit:
- Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.1996
- The genetics of breast and ovarian cancerBritish Journal of Cancer, 1995
- Inherited breast and ovarian cancerHuman Molecular Genetics, 1995
- Germline mutation of BRCA1 in Japanese breast cancer families.1995
- Pharmacogenetics: detecting sensitive populations.Environmental Health Perspectives, 1994
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Antioncogenes and human cancer.Proceedings of the National Academy of Sciences, 1993
- Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.1993
- The genetic predisposition to cancer.1989
- Hereditary cancer, oncogenes, and antioncogenes.1985